Johnson & Johnson submits regulatory applications to

        Media contact:Sophie DaneauSdaneau@its.jnj.com+33 6 3178 8798Investor contact:Raychel Kruperinvestor-relations@its.jnj.com For European and UK...

Related Keywords

Japan ,United Kingdom ,Canada ,Belgium ,Beerse ,Region Flamande ,Canadian ,David Lee ,Sophie Daneau ,Drug Administration ,Johnson ,Japan Pharmaceuticals ,Exchange Commission ,European Union ,Canadian Agency For Drugs Technologies In Health ,Janssen Biotech Inc ,Crohn Colitis Foundation ,None Of Janssen Research Development ,Devices Agency ,Janssen Research Development ,European Medicines Agency ,Janssen Cilag International ,Marketing Authorisation Application ,Ludovic De Beaucoudrey ,Senior Director ,Therapeutic Area Lead ,Janssen Cilag Limited ,Global Therapeutic Area Head Immunology ,Johnson Innovative ,Disease Week Annual Meeting ,United European Gastroenterology Week ,Biologics License Application ,Innovative Medicine ,Middle East ,Janssen Research ,Janssen Biotech ,Private Securities Litigation Reform Act ,Annual Report ,Note Regarding Forward Looking ,Quarterly Reports ,Trials Register ,Accessed April ,Digestive Disease Week ,European Medicines ,Last Updated July ,Canadian Agency ,Medical Devices ,Tremfya Report ,Janssen Emea ,Ohnson Amp Johnson ,Mmunology ,Tremfya ,